Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
PTCT
PTCT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
PTCT News
Healthcare Stocks Decline Late Friday Afternoon
2d ago
Yahoo Finance
PTC Therapeutics Raises Full-Year Outlook Amid Strong Sephience Launch
2d ago
seekingalpha
PTC Therapeutics Reports Record Q1 2026 Earnings with Raised Guidance
3d ago
seekingalpha
PTC Therapeutics Reveals Long-Term Results for Votoplam in Huntington's Disease
Apr 28 2026
NASDAQ.COM
PTC and Novartis Advance Huntington's Disease Research with Votoplam
Apr 28 2026
PRnewswire
PTC and Novartis Announce Votoplam Study Progress
Apr 28 2026
Newsfilter
PTC Therapeutics Approves Stock Options and RSUs for New Hire
Apr 17 2026
PRnewswire
PTC Therapeutics Approves Stock Options and RSUs for New Hire
Apr 17 2026
Newsfilter
PTC Appoints Biotechnology Investment Banker to Board
Mar 25 2026
PRnewswire
PTC Appoints Biotechnology Expert to Board
Mar 25 2026
Newsfilter
RTW Investments Takes New Stake in Apellis Pharmaceuticals
Mar 22 2026
Yahoo Finance
RTW Investments Increases Stake in Cogent Biosciences by $116 Million
Mar 22 2026
Yahoo Finance
PTC Therapeutics Approves Employee Stock Options
Mar 13 2026
PRnewswire
PTC Therapeutics Approves Employee Stock Options
Mar 13 2026
Newsfilter
UniQure's Gene Therapy Faces FDA Challenges
Mar 05 2026
CNBC
Palo Alto Investors Increases Stake in PTC Therapeutics
Mar 03 2026
Fool
Show More News
